abafungin,
Abafungin,
129639-79-8,
abafungina,
abafungine,
abafunginum,
bay w 6341,
UNII-11DI31LWXF,
N-[4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl]-1,4,5,6-tetrahydropyrimidin-2-amine,
11DI31LWXF,
4-(2-(2,4-Dimethylphenoxy)phenyl)-N-(1,4,5,6-tetrahydropyrimidin-2-yl)thiazol-2-amine,
BAY-W 6341,
C21H22N4OS,
Abasol,
4-[2-(2,4-dimethylphenoxy)phenyl]-N-(1,4,5,6-tetrahydropyrimidin-2-yl)-1,3-thiazol-2-amine,
Abafungin [INN:BAN],
AC1Q4URQ,
AC1L4LN6,
SCHEMBL301668,
BAY-w-6341,
CHEMBL3989547,
SCHEMBL12795940,
CHEBI:76005,
BAY-W-6341-,
BCP08353,
KS-000000VO,
ZINC3938976,
6067AH,
MFCD00942263,
AKOS030228042,
API0025846,
DB06395,
TRA0085256,
AT-24299,
A-8607,
639A798,
J-005698,
Hexahydro-2-((4-(o-(2,4-xylyloxy)phenyl)-2-thiazolyl)imino)pyrimidine,
2-Pyrimidinamine, N-[4-[2-(2,4-dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-,
N-[4-[2-(2,4-Dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine,
N-{4-[2-(2,4-dimethylphenoxy)phenyl]-1,3-thiazol-2-yl}tetrahydropyrimidin-2(1H)-imine,
D08MTG,
C21-H22-N4-O-S,
AR-1H7782,
AR-1H7783,
CID159326,
YP-006,
YP-007,
Abafungin (gel formulation), York Pharma,
W-634,
Abafungin (cream, dermatomycosis), York Pharma,
Abafungin (pessary, vaginal candidiasis), York Pharma,
Abafungin (gel formulation, onychomycosis), York Pharma,
15116-90-2,
15118-67-9,